New Aspects of Gene-Silencing for the Treatment of Cardiovascular Diseases
Open Access
- 19 July 2013
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 6 (7) , 881-914
Abstract
Coronary heart disease (CHD), mainly caused by atherosclerosis, represents the single leading cause of death in industrialized countries. Besides the classical interventional therapies new applications for treatment of vascular wall pathologies are appearing on the horizon. RNA interference (RNAi) represents a novel therapeutic strategy due to sequence-specific gene-silencing through the use of small interfering RNA (siRNA). The modulation of gene expression by short RNAs provides a powerful tool to theoretically silence any disease-related or disease-promoting gene of interest. In this review we outline the RNAi mechanisms, the currently used delivery systems and their possible applications to the cardiovascular system. Especially, the optimization of the targeting and transfection procedures could enhance the efficiency of siRNA delivery drastically and might open the way to clinical applicability. The new findings of the last years may show the techniques to new innovative therapies and could probably play an important role in treating CHD in the future.Keywords
This publication has 188 references indexed in Scilit:
- Surface-Modified HK:siRNA Nanoplexes with Enhanced Pharmacokinetics and Tumor Growth InhibitionBiomacromolecules, 2013
- Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemiaNeurobiology of Disease, 2012
- Regulation of Tumor Angiogenesis by EZH2Cancer Cell, 2010
- Effect of Nanoparticle Surface Charge at the Plasma Membrane and BeyondNano Letters, 2010
- Non-viral systemic delivery of Fas siRNA suppresses cyclophosphamide-induced diabetes in NOD miceJournal of Controlled Release, 2010
- MMP-9 gene silencing by a quantum dot–siRNA nanoplex delivery to maintain the integrity of the blood brain barrierBrain Research, 2009
- Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cellsBiomaterials, 2008
- siRNA silencing reveals role of vascular cell adhesion molecule-1 in vascular smooth muscle cell migrationAtherosclerosis, 2008
- Lung Delivery Studies Using siRNA Conjugated to TAT(48−60) and Penetratin Reveal Peptide Induced Reduction in Gene Expression and Induction of Innate ImmunityBioconjugate Chemistry, 2007
- Inhibition of the α1D-adrenergic receptor gene by RNA interference (RNAi) in rat vascular smooth muscle cells and its effects on other adrenergic receptorsVascular Pharmacology, 2007